2023
Cognitive behavioral therapy following esketamine for major depression and suicidal ideation for relapse prevention: The CBT-ENDURE randomized clinical trial study protocol
Kitay B, Murphy E, Macaluso M, Corlett P, Hershenberg R, Joormann J, Martinez-Kaigi V, Nikayin S, Rhee T, Sanacora G, Shelton R, Thase M, Wilkinson S. Cognitive behavioral therapy following esketamine for major depression and suicidal ideation for relapse prevention: The CBT-ENDURE randomized clinical trial study protocol. Psychiatry Research 2023, 330: 115585. PMID: 37935086, DOI: 10.1016/j.psychres.2023.115585.Peer-Reviewed Original ResearchConceptsCognitive behavioral therapyMajor depressionSuicidal ideationRelapse preventionBehavioral therapyStudy protocolHigh riskClinical trial study protocolLong-term treatment approachKey secondary outcomesTrial study protocolHigh relapse rateHigh-risk populationSignificant suicidal ideationHospital dischargeSecondary outcomesPrimary outcomeRelapse rateFeasibility trialEsketamineTreatment approachesPatientsSuicide attemptsTherapySupplemental indications
2019
DEPRESSIVE DISORDERS IN OLDER ADULTS ASSOCIATIONS OF ADVERSE CHILDHOOD EXPERIENCES WITH DSM-5 DEPRESSIVE DISORDERS AND SUICIDE ATTEMPT IN OLDER ADULTS
Rhee T, Barry L, Kuchel G, Steffens D, Wilkinson S. DEPRESSIVE DISORDERS IN OLDER ADULTS ASSOCIATIONS OF ADVERSE CHILDHOOD EXPERIENCES WITH DSM-5 DEPRESSIVE DISORDERS AND SUICIDE ATTEMPT IN OLDER ADULTS. Innovation In Aging 2019, 3: s571-s572. PMCID: PMC6841627, DOI: 10.1093/geroni/igz038.2117.Peer-Reviewed Original ResearchAdverse childhood experiencesMajor depressive disorderDepressive disorderLifetime suicide attemptsSuicide attemptsOlder adultsHigher oddsForms of ACEsMultivariable-adjusted logistic regression analysesPast-year major depressive disorderAssociation of ACEsDSM-5 depressive disordersPrevalence of ACEsImportant public health goalRelated Conditions Wave IIIUS older adultsLogistic regression analysisNational Epidemiological SurveyPublic health goalsDSM-5 criteriaChildhood experiencesLong-term benefitsNational prevalenceLong-term effectsMood disorders